YALE UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia
Phase 4
Completed
- Conditions
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2014-06-06
- Lead Sponsor
- Yale University
- Registration Number
- NCT00237861
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- Yale University
- Target Recruit Count
- 104
- Registration Number
- NCT00237809
- Locations
- 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States
🇺🇸VA Connecticut Healthcare System, West Haven, Connecticut, United States
D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2012-06-18
- Lead Sponsor
- Yale University
- Target Recruit Count
- 72
- Registration Number
- NCT00237848
- Locations
- 🇮🇳
National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India
Increasing Treatment Adherence in Co-Occurring Psychiatric and Drug Use Disorders
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2017-10-17
- Lead Sponsor
- Yale University
- Target Recruit Count
- 75
- Registration Number
- NCT00237822
- Locations
- 🇺🇸
Yale University Substance Abuse Center, New Haven, Connecticut, United States
Culturally Responsive Person-Centered Care for Psychosis
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-10-04
- Last Posted Date
- 2020-04-02
- Lead Sponsor
- Yale University
- Target Recruit Count
- 290
- Registration Number
- NCT00231933
- Locations
- 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States
Therapeutic Substance Abuse Treatment in Pregnancy - 1
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-28
- Last Posted Date
- 2020-04-15
- Lead Sponsor
- Yale University
- Target Recruit Count
- 168
- Registration Number
- NCT00227903
- Locations
- 🇺🇸
Bridgeport Hospital, Bridgeport, Connecticut, United States
🇺🇸Yale-New Haven Hospital, New Haven, Connecticut, United States
Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics
Completed
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2005-09-22
- Lead Sponsor
- Yale University
- Target Recruit Count
- 100
- Registration Number
- NCT00224276
Effect of Age on Latanoprost 0.005% in Patients With Glaucoma
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2012-12-10
- Lead Sponsor
- Yale University
- Target Recruit Count
- 17
- Registration Number
- NCT00224289
- Locations
- 🇺🇸
Yale Eye Center, New Haven, Connecticut, United States
Ultrasound Study of the Uterine Healing Process After Cesarean Delivery
Not Applicable
Completed
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2018-03-13
- Lead Sponsor
- Yale University
- Target Recruit Count
- 30
- Registration Number
- NCT00224250
- Locations
- 🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States
Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2015-07-30
- Lead Sponsor
- Yale University
- Target Recruit Count
- 86
- Registration Number
- NCT00142909
- Locations
- 🇺🇸
Yale University, Psychiatry, New Haven, Connecticut, United States
© Copyright 2024. All Rights Reserved by MedPath